Skip to main content
SYK $339.21 -0.55%
SYK logo

SYK · Stryker Corp

Track SYK — free
$339.21 -1.88 (-0.55%) At close · Aug 14
Market Cap
$130.11B
Shares
383.57M
All earnings calls

Earnings call · FY2026 Q2

Stryker's Q2 2026 Earnings Call

Stryker's Q2 2026 Earnings Call

Concluded Jul 30, 2026
Jul 30, 2026 0 turns
Period
FY2026 Q2
Runtime
Sources
2 artifacts

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.

Forward guidance

2 guided metrics

Management's latest ranges and targets are included below.

Research coverage

2 live sources

Switch sources without leaving this page or losing your listening position.

Revenue $6.59B +9.4% YoY
Diluted EPS $3.30 +44.1% YoY
Gross margin 68.3% +4.5 pp YoY
Net income $1.28B +44.3% YoY

Research materials

Open the source you need; every reader stays inside this workspace.

Forward guidance

From the 8-K filed Jul 30, 2026.

Metric Guided
Organic net sales growth
full year 2026
8.3% – 9.3%
Adjusted net earnings per diluted share
full year 2026
$14.95 – $15.10

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

Neuro Cranial Instruments$681.00M +10.6% YoY
Orthopaedic Instruments$523.00M +4.4% YoY
Other Orthopedics$194.00M +31.1% YoY
Enabling Technologies$28.00M -17.6% YoY

Capital returned

Dividend / share
$0.88
Full-screen source Call document